Introduction: When developing a generic drug product, pharmaceutical companies must decide which type of external partner best fits their needs. […]
CDMO vs CRO for Generic Drug Development: Which Partner Do You Need? Read More »
Introduction Pharmaceutical companies often receive regulatory questions about nitrosamine impurities during submissions, variations, or post-approval reviews. When this happens, organizations
How to Respond to a Regulatory Query on Nitrosamine Risk Assessment Read More »
Introduction Peptide Oligonucleotide Conjugates Preclinical Services play an important role in supporting the development of Peptide Oligonucleotide Conjugates (POCs), which
Introduction: Analytical development for generic drugs Canada is a critical component of successful generic drug development and regulatory approval. Generic
Analytical Development Support from CDMOs for Generic Drug Projects Read More »
Introduction: Outsourcing generic drug development Canada has become a strategic approach for pharmaceutical companies looking to accelerate market entry, reduce
Outsourcing Generic Drug Development in Canada: Why Pharma Companies Work with CDMOs Read More »
Introduction: The Generic pharmaceutical CDMO ecosystem plays a critical role in helping pharmaceutical companies develop and commercialize high-quality generic medicines.
Contract Development and Manufacturing for Generic Pharmaceuticals in Canada Read More »
Introduction: A CDMO for generic projects in Canada plays a critical role in helping pharmaceutical companies develop and commercialize generic
CDMO for Generic Projects in Canada: Services, Capabilities, and Regulatory Support Read More »
Introduction: Choosing the right CDMO for generic drug development in Canada is one of the most important decisions pharmaceutical companies
How to Choose the Right CDMO for Generic Drug Development in Canada Read More »
Introduction: A well-planned Bioanalytical Strategy Drug Development framework is critical for the success of early drug development programs. Without reliable
Why Early Drug Development Programs Fail Without Strong Bioanalytical Strategy Read More »
Introduction: The journey from drug discovery to human clinical trials is complex, expensive, and highly regulated. One of the most
From Discovery to First-in-Human: The Role of Bioanalytical CROs Read More »
